Das equine maligne Lymphom – zwei Fälle mit unterschiedlicher klinischer Präsentation

Literatur
1 Brosnahan MM, Paradis MR. Demographic and clinical characteristics of geriatric horses: 467 cases (1989–1999). J Am Vet Med Assoc 2003; 223: 93-98
2 Burns TA, Couto CG. Systemic Chemotherapy for oncologic Diseases. In: Robinson NE, ed. Current Therapy in equine Medicine. St. Louis: Saunders; 2009: 15-18
3 Dabareiner RM, Sullins KE, Goodrich LR. Large colon resection for treatment of lymphosarcoma in two horses. J Am Vet Med Assoc 1996; 208: 895-897
4 Elce YA. Neoplastic Disease of the gastrointestinal Tract. In: Robinson NE, ed. Current Therapy in equine Medicine. St. Louis: Saunders; 2009: 448-450
5 Gerard M, Pruitt A, Thrall DE. Radiation therapy communication: nasal passage and paranasal sinus lymphoma in a pony. Vet Radiol Ultrasound 2010; 51: 97-101
6 Henson FMD, Dixon K, Dobson JM. Treatment of 4 cases of equine lymphoma with megavoltage radiation. Equine Vet Educ 2004; 16: 312-314
7 Henson FMD, Dobson JM. Use of radiation therapy in the treatment of equine neoplasia. Equine Vet Educ 2004; 16: 315-318
8 Henson KL, Alleman AR, Cutler TJ, Ginn PE, Kelley LC. Regression of subcutaneous lymphoma following removal of an ovarian granulosa-theca cell tumor in a horse. J Am Vet Med Assoc 1998; 212: 1419-1422
9 Kelley LC, Mahaffey EA. Equine malignant lymphomas: morphologic and immunohistochemical classification. Vet Pathol 1998; 35: 241-252
10 Lane JG. Palatine lymphosarcoma in 2 horses. Equine Vet J 1985; 17: 465-467
11 Lester GD, Mackay RJ, Smithmeyer B. Primary meningeal lymphoma in a horse. J Am Vet Med Assoc 1992; 201: 1219-1221
12 Mair TS, Couto CG. The use of cytotoxic drugs in equine practice. Equine Vet Educ 2006; 18: 149-156
13 Mammerick X. Etude epizoologique sur les leucoses des animaux domestiques en Belgique de 1961 a 1970. Ann Med Vet 1972; 116: 157-166
14 McClure JT. Leukoproliferative disorders in horses. Vet Clin North Am Equine Pract 2000; 16: 165-182
15 Meyer J, Delay J, Bienzle D. Clinical, laboratory, and histopathologic features of equine lymphoma. Vet Pathol 2006; 43: 914-924
16 Montgomery JB, Duckett WM, Bourque AC. Pelvic lymphoma as a cause of urethral compression in a mare. Can Vet J 2009; 50: 751-754
17 Neufeld JL. Lymphosarcoma in the horse – review. Can Vet J 1973; 14: 129-135
18 Pinkerton ME, Bailey KL, Thomas KK, Goetz TE, Valli VE. Primary epitheliotropic intestinal T-cell lymphoma in a horse. J Vet Diag Invest 2002; 14: 150-152
19 Reef VB, Dyson SS, Beech J. Lymphosarcoma and associated immune-mediated hemolytic anemia and thrombocytopenia in horses. J Am Vet Med Assoc 1984; 184: 313-317
20 Rhind SM, Dixon PM. T cell-rich B cell lymphosarcoma in the tongue of a horse. Vet Rec 1999; 145: 554-555
21 Saulez MN, Schlipf JW, Cebra CK, McDonough SP, Bird KE. Use of chemotherapy for treatment of a mixed-cell thoracic lymphoma in a horse. J Am Vet Med Assoc 2004; 224: 733-738
22 Savage CJ. Lymphoproliferative and myeloproliferative disorders. Vet Clin North Am Equine Pract 1998; 14: 563-578 vii
23 Schalm O. Lymphosarcoma in the horse. Equine Pract 1981; 23-26
24 Schneider D. Lymphoproliferative and myeloproliferative Disorders. In: Robinson NE, ed. Current Therapy in equine Medicine. St. Louis: Saunders; 2003: 359-362
25 Schott II HC. Cutaneous Manifestations of systemic Disease. In: Robinson NE, ed. Current Therapy in equine Medicine. St. Louis: Saunders; 2009: 709-712
26 Schumacher J. Infiltrative Bowel Diseases. In: Robinson NE, ed. Current Therapy in Equine Medicine. St. Louis: Saunders; 2009: 439-442
27 Sellon DC, Wise LN. Disorders of the hematopoetic system – hematopoetic Neoplasia. In: Reed SM, Bayly WM, Sellon DC, eds. Equine internal Medicine. St. Louis: Saunders; 2010: 747-749
28 Taintor J, Schleis S. Equine lymphoma. Equine Vet Educ 2011; 23: 205-213
29 Van den Hoven R, Franken P. Clinical aspects of lymphosarcoma in the horse – a clinical report of 16 cases. Equine Vet J 1983; 15: 49-53
30 Williams N. Disease conditions in geriatric horses. Equine Pract 2000; 22: 32-32